Hero: See where healthcare visibility breaks before it becomes trust, adoption or revenue. Bullzeye evaluates whether the people and systems shaping healthcare decisions can find, understand, verify and act on your organization. |
Your organization may rank for priority terms and still be absent from physician referrals, institutional evaluation, payer consideration or AI-generated answers. It may be mentioned without being cited, visible without being credible, or trusted without providing a usable next step. The Healthcare Visibility Assessment shows where the decision system is breaking and which gaps deserve action.
Can priority audiences find the organization, service, expertise or solution through the channels they actually use? Evidence may include organic search presence, local discovery, professional directories, referral pathways, industry media, conference visibility and relevant third-party pages.
Can search and AI systems extract a clear, accurate answer from the organization’s content? The assessment looks for direct definitions, coherent entities, retrievable facts, explicit relationships, structured content and language that answers the real question rather than merely repeating brand claims.
Is the organization named, referenced or recommended by AI engines and authoritative external sources? Citability includes the frequency and context of mentions, the quality and diversity of sources, attribution accuracy, citation consistency and whether competitors control the sources shaping the answer.
Can material claims, expertise, evidence and leadership be independently verified? This dimension evaluates visible authorship, reviewer credentials, source quality, evidence boundaries, institutional corroboration, dated updates and the difference between claimed authority and verified authority.
Is the organization visible across the actual patient, referral, procurement, adoption or partnership journey? The question is not whether a page exists. It is whether each decision-maker encounters the proof needed at the stage where uncertainty would otherwise stop progress.
Can visibility move into an appropriate next action, such as a referral, inquiry, evaluation, appointment or partnership conversation? This dimension examines conversion paths, proof near the decision, handoffs, response systems and the breakpoints between attention and commercial movement.
The assessment is designed for healthcare providers, physician groups, MedTech and healthtech companies, and growth-stage healthcare organizations facing a commercial inflection point. It is most useful when leadership sees activity but cannot explain why authority, adoption, qualified demand or revenue is not moving with it.
Define the organization, market, audience, decision path, competitors and collection period.
Capture search, AI, content, third-party, buyer and commercial signals.
Evaluate approved indicators across six equally weighted dimensions.
Assign the evidence-confidence level and document contradictions.
Prioritize the smallest interventions capable of changing the material decision path.
Measure what the market and commercial system actually confirm.
The Healthcare Visibility Assessment does not rate clinical quality, patient outcomes or product efficacy. It does not guarantee rankings, AI citations or revenue. It measures whether relevant evidence is visible and verifiable within a defined scope, then supports a governed decision about what to do next.
The value is not the composite number. The assessment is decision-useful when leadership can trace each priority back to a specific audience, stopping question, source and commercial consequence. A recommendation should therefore identify the accountable owner, the mechanism expected to change, the baseline signal and the date on which Bullzeye will re-test the decision path. If those fields are missing, the output is still an audit rather than a governed intervention plan.
The assessment also preserves negative evidence. If buyers cannot verify a claim, if an AI engine repeatedly cites a competitor, if a physician referral path lacks required information or if a commercial handoff fails, those observations remain in the scorebook even when they challenge the preferred strategy. That discipline is what allows the evidence-confidence grade to mean something. It gives the executive team a basis for deciding what to fund now, what to test cheaply and what not to claim yet.
Primary CTA: Request a Healthcare Visibility Assessment. Secondary CTA: Download the Healthcare Visibility Executive Scorecard.
No. SEO contributes to discoverability, but the assessment also measures answerability, citability, credibility, decision-path presence and commercial continuity.
Each of the six dimensions contributes 16.67 points.
Yes, within the named market and comparison scope approved at the start.
Yes. It evaluates relevant AI descriptions, citations, sources and entity accuracy as part of answerability and citability.
Every result is labeled Directional, Supported or Decision-grade.
No. The assessment does not score care quality, outcomes or efficacy.